PURPOSE: Multiple studies have shown survival benefits in patients with cancer treated with radiation therapy, but access to treatment facilities has been found to limit its use. This study was undertaken to examine access issues in Iowa and determine a methodology for conducting a similar national analysis. PATIENTS AND METHODS: All Iowa residents who received radiation therapy regardless of where they were diagnosed or treated were identified through the Iowa Cancer Registry (ICR). Radiation oncologists were identified through the Iowa Physician Information System (IPIS). Radiation facilities were identified through IPIS and classified using the Commission on Cancer accreditation standard. RESULTS: Between 2004 and 2010, 113,885 invasive cancers in 106,603 patients, 28.5% of whom received radiation treatment, were entered in ICR. Mean and median travel times were 25.8 and 20.1 minutes, respectively, to the nearest facility but 42.4 and 29.1 minutes, respectively, to the patient's chosen treatment facility. Multivariable analysis predicting travel time showed significant relationships for disease site, age, residence location, and facility category. Residents of small and isolated rural towns traveled nearly 3× longer than urban residents to receive radiation therapy, as did patients using certain categories of facilities. CONCLUSION: Half of Iowa patients could reach their nearest facility in 20 minutes, but instead, they traveled 30 minutes on average to receive treatment. The findings identified certain groups of patients with cancer who chose more distant facilities. However, other groups of patients with cancer, namely those residing in rural areas, had less choice, and some had to travel considerably farther to radiation facilities than urban patients.
PURPOSE: Multiple studies have shown survival benefits in patients with cancer treated with radiation therapy, but access to treatment facilities has been found to limit its use. This study was undertaken to examine access issues in Iowa and determine a methodology for conducting a similar national analysis. PATIENTS AND METHODS: All Iowa residents who received radiation therapy regardless of where they were diagnosed or treated were identified through the Iowa Cancer Registry (ICR). Radiation oncologists were identified through the Iowa Physician Information System (IPIS). Radiation facilities were identified through IPIS and classified using the Commission on Cancer accreditation standard. RESULTS: Between 2004 and 2010, 113,885 invasive cancers in 106,603 patients, 28.5% of whom received radiation treatment, were entered in ICR. Mean and median travel times were 25.8 and 20.1 minutes, respectively, to the nearest facility but 42.4 and 29.1 minutes, respectively, to the patient's chosen treatment facility. Multivariable analysis predicting travel time showed significant relationships for disease site, age, residence location, and facility category. Residents of small and isolated rural towns traveled nearly 3× longer than urban residents to receive radiation therapy, as did patients using certain categories of facilities. CONCLUSION: Half of Iowa patients could reach their nearest facility in 20 minutes, but instead, they traveled 30 minutes on average to receive treatment. The findings identified certain groups of patients with cancer who chose more distant facilities. However, other groups of patients with cancer, namely those residing in rural areas, had less choice, and some had to travel considerably farther to radiation facilities than urban patients.
Authors: Leslie K Ballas; Elena B Elkin; Deborah Schrag; Bruce D Minsky; Peter B Bach Journal: Int J Radiat Oncol Biol Phys Date: 2006-11-15 Impact factor: 7.038
Authors: Maria O Celaya; Judy R Rees; Jennifer J Gibson; Bruce L Riddle; E Robert Greenberg Journal: Cancer Causes Control Date: 2006-08 Impact factor: 2.506
Authors: Anneke T Schroen; David R Brenin; Maria D Kelly; William A Knaus; Craig L Slingluff Journal: J Clin Oncol Date: 2005-10-01 Impact factor: 44.544
Authors: Lydia Voti; Lisa C Richardson; Isildinha M Reis; Lora E Fleming; Jill Mackinnon; Jan Willem W Coebergh Journal: Cancer Date: 2006-01-01 Impact factor: 6.860
Authors: Marcia M Ward; Fred Ullrich; Kevin Matthews; Gerard Rushton; Michael A Goldstein; Dean F Bajorin; Amy Hanley; Charles F Lynch Journal: J Oncol Pract Date: 2013-01 Impact factor: 3.840
Authors: Kirsten M M Beyer; Audrey F Saftlas; Anne B Wallis; Corinne Peek-Asa; Gerard Rushton Journal: Int J Health Geogr Date: 2011-01-10 Impact factor: 3.918
Authors: Neha Vapiwala; Charles R Thomas; Surbhi Grover; Mei Ling Yap; Timur Mitin; Lawrence N Shulman; Mary K Gospodarowicz; John Longo; Daniel G Petereit; Ronald D Ennis; James A Hayman; Danielle Rodin; Jeffrey C Buchsbaum; Bhadrasain Vikram; May Abdel-Wahab; Alan H Epstein; Paul Okunieff; Joel Goldwein; Patrick Kupelian; Joanne B Weidhaas; Margaret A Tucker; John D Boice; Clifton David Fuller; Reid F Thompson; Andrew D Trister; Silvia C Formenti; Mary-Helen Barcellos-Hoff; Joshua Jones; Kavita V Dharmarajan; Anthony L Zietman; C Norman Coleman Journal: Int J Radiat Oncol Biol Phys Date: 2019-05-22 Impact factor: 7.038
Authors: Pooja Rao; Joel E Segel; Lisa M McGregor; Eugene J Lengerich; Joseph J Drabick; Barbara Miller Journal: J Adolesc Young Adult Oncol Date: 2019-10-10 Impact factor: 2.223
Authors: Ingrid M Lizarraga; Amanda R Kahl; Ellie Jacoby; Mary E Charlton; Charles F Lynch; Sonia L Sugg Journal: Breast Cancer Res Treat Date: 2021-02-13 Impact factor: 4.624
Authors: Marilyn Lyford; Margaret M Haigh; Siddhartha Baxi; Shelley Cheetham; Shaouli Shahid; Sandra C Thompson Journal: Int J Environ Res Public Health Date: 2018-02-14 Impact factor: 3.390